Explainer: Move attributed to ‘insufficient data’ but experts say no evidence vaccine doesn’t work
German authorities have advised that the Oxford/AstraZeneca jab should not be given to those aged 65 or above. We take a look at why, and what experts make of it.
Why has Germany advised the Oxford/AstraZeneca jab should only be used in adults under 65?
Continue reading...Nobody in Moldova has received a Covid jab yet – and our neglected healthcare system is unable to cope
“I am happy to work on the frontline and to see the Canadian medical system function so well,” Alecu Mătrăgună wrote in a Facebook post, “but I am sad that I was vaccinated before my mother, who works in the medical system in Moldova.” Mătrăgună is a Moldovan sonographer living in Montreal. His mother is 61 and a paediatrician with more than 30 years’ service under her belt. Yet, he told me, she has no idea when the Covid-19 vaccine might become available for her and for more than 53,300 other healthcare staff in Europe’s poorest country.
I had a similar reaction to Mătrăgună’s about my family in Moldova when I saw a sign at my local London pharmacy as long ago as early December, announcing that the vaccine was on its way. At the time, my grandmother had just recovered and my father was still battling with the effects of the virus.
Continue reading...Albanese pins election hopes on major reshuffle; Australia extends travel bubble suspension with NZ; Another 350 jobs to go at Virgin Australia. Follow the latest updates live
• NSW hotspots; State-by-state restrictions and rules explained
• Qld to reopen border to all of NSW on 1 February
• Follow the global coronavirus liveblog
Guardian Australia contacted CSL to ask for more information about why the manufacturing company did not send a representative to appear before the Senate Covid-19 Committee.
While CSL told the Committee it was too busy to appear, other major companies, including Pfizer and AstraZeneca, have appeared. Pfizer appeared despite currently trying to meet a tight deadline of delivering its vaccine for roll-out in Australia by the end of the month.
It is totally disrespectful for CSL, the recipient of $1.7 billion in taxpayer funded vaccine related contracts, to refuse to appear before today’s Senate COVID Committee. If they won’t respect the Senate’s request, they should expect a ‘subpoena’. #auspol https://t.co/ZS3gMO8VoE
CSL appreciates invitation to attend the Senate Select Committee Hearing on COVID-19. Due to our commitment to urgently deliver 50 million doses of a safe and effective COVID-19 vaccine we are unable to resource our participation at this time.
In response to the global pandemic, CSL employees allocated to the COVID-19 vaccine program are fully focussed and working around the clock to ensure vaccines are available for use in Australia as soon as possible. We will be in a better position to consider a similar invitation later in the year.
Virgin Australia has cut another 350 jobs, this time at its head office in Brisbane, the Australian Services Union says.
It comes on top of more than 3000 sackings at the airline since it was bought by US investment group Bain Capital last year after going into administration due to the coronavirus crisis.
Continue reading...With a vaccine-hesitant public and jabs yet to begin, there are fears immunisations are off the pace
Japan was among the first countries to report cases of Covid-19 after the world was alerted to the virus in December 2019. But just over a year later, it is the last major economy to deploy a vaccine – a measure widely acknowledged as the best hope for a return to something resembling normal life.
The first round of jabs is not expected to begin in Japan until the end of February, months after the US and UK – which have recorded far higher death tolls and caseloads – began their vaccination programmes.
Continue reading...EU health commissioner dismisses AstraZeneca argument it is contractually obliged to supply UK first
Britain is on a collision course with the European Union over vaccine shortages after Brussels refused to accept that people in the UK have first claim on Oxford/AstraZeneca doses produced in local plants.
The EU’s health commissioner outright dismissed on Wednesday an argument made by Pascal Soriot, the Anglo-Swedish company’s chief executive, that he was contractually obliged to supply the UK first.
Continue reading...The UK needs to learn from the lessons of the past year and come up with a concrete plan to avert a disastrous third wave
Yesterday Britain passed a grim milestone. A further 1,631 deaths from Covid-19 were recorded, taking the official tally above 100,000, though data from the Office for National Statistics suggests the total number will now be nearer 120,000. In a briefing, Boris Johnson has said his government did everything it could to minimise the loss of life, but these deaths were far from inevitable. While the number of UK deaths has entered the hundreds of thousands, New Zealand has recorded only 25 deaths from Covid-19 so far. Taiwan has recorded seven, Australia 909, Finland 655, Norway 550 and Singapore 29. These countries have largely returned to normal daily life.
In the first year of the pandemic, the UK faced three big challenges. Our national government had no long-term strategy for suppressing the virus beyond a continual cycle of lockdowns. Even now we still don’t know what the government’s plans for the next six months are. In the early days of the pandemic, the UK treated Covid-19 like a bad flu. The government halted testing, and the initial plan seemed to be allow the virus to run unchecked through the population (the “herd immunity” approach). Finally, ministers have pitted the economy against public health, instead of realising that the health of the economy depends upon a healthy population.
Continue reading...Chief executive of pharmaceutical giant says the firm will honour UK’s earlier contract despite EU anger over shortfall
AstraZeneca’s chief executive has insisted the UK will come first for vaccines as he rejected calls to divert doses to the European Union following a breakdown in supply.
Amid a growing row, Pascal Soriot, the French head of the pharmaceutical giant, said the UK was benefiting from being early to sign a contract for 100m doses.
Continue reading...European Medicines Agency approval could stipulate age range, suggests Emer Cooke
The Oxford/AstraZeneca vaccine may be authorised only for younger people in Europe, because there is insufficient data on how well it works in the over-65s, the head of the regulatory body has suggested.
The European Medicines Agency (EMA) is expected to authorise the AstraZeneca vaccine at the end of this week, a month after it was approved in the UK.
Continue reading...Analysis: technical problem at Belgium plant failed to produce enough vaccine but EU demanding fulfilment of contract
AstraZeneca warned the European commission on Friday that there would be a significant shortfall in the promised 100m vaccine doses this quarter, of up to 60%. It says this is due to a technical issue: not enough vaccine is being produced by the main plant making the supplies destined for Europe, which is in Belgium.
Continue reading...Analysis: Drug company and scientific partners at Oxford University have strongly pushed back against German press report
A row has broken out after German newspapers suggested the Oxford/AstraZeneca vaccine might have a lower efficacy among the over-65s. Below we take a look at the claims, and whether we should be concerned.
Continue reading...Commission president says firms must deliver on orders after AstraZeneca warns of shortfall
The EU “means business”, Ursula von der Leyen has said, as the bloc doubled down on plans for tighter monitoring of vaccine exports to countries outside of the union, such as the UK.
Speaking at the World Economic Forum, the president of the European commission said the EU had invested billions and “companies must now deliver” to the 27 member states.
Continue reading...A group of celebrities have released a video addressing vaccine misinformation in BAME communities.
The group, including actors Adil Ray and Meera Syal, as well as cricketeer Moeen Ali and presenter Konnie Huq, appealed to black, Asian and ethnic minority communities in the UK to help address hesitancy around the Covid-19 vaccine.
Coronavirus has disproportionately impacted minority ethnic communities, but these communities have also been subject to misleading information around the vaccine.
‘Unfortunately we are now fighting another pandemic: misinformation,’ Ray, who helped organise the video, explained. ‘We all must do what we can and come together to fight this deadly virus. We hope this video can help dispel some of the myths and offer some encouragement for everyone to take the vaccine’
Continue reading...Late February Pfizer vaccine rollout planned. Meanwhile, South Australian authorities warn residents as bushfires erupt in Adelaide Hills. Follow all the latest updates, live
• NSW hotspots; Queensland hotspots
• State-by-state restrictions and lockdown rules explained
• Pfizer Covid vaccine approved for Australian rollout
• Follow the global coronavirus liveblog
A truck carrying toilet paper has burst into flames, causing traffic chaos on Melbourne’s Eastern Freeway.
It is still unclear what caused the fire, but firefighters are on the scene, attempting to bring the fire under control.
The truck exploding into flames on the Eastern Freeway, Melbourne near the Elgar Rd exit. I saw this while passing by and hope no one is hurt. The fire is now out but traffic is banked up on the city-bound lane. A terrible incident on a 40c day. #truckOnFireMelbourneFreeway pic.twitter.com/tj5MANXAQh
The Bureau of Meteorology has said the heatwave is over in Melbourne and is easing in South Australia, with rain and thunderstorms expected later this evening.
Dean Narramore, a senior meteorologist at the BoM, warned that the focus will shift to New South Wales tomorrow, with temperatures forecast to get near 40C in Western Sydney, with the city expecting to reach 35C.
But by tomorrow night the cool change will have moved across all of south-eastern Australia and temperatures will return to near seasonal averages for the rest of the week.
Continue reading...More vaccination centres open as experts call for monitoring of effect of lengthy gap between jabs
Experts have called for greater clarity about the monitoring in place to assess the 12-week dosing interval for Covid vaccines, as the UK’s vaccination programme ramps up.
According to government data released on Sunday, a total of 6,353,321 people in the UK have received at least one dose of a Covid vaccine. A further slew of vaccination centres are due to open on Monday to speed up delivery of the jabs.
Continue reading...JCVI deputy chair defends extended gap between jabs as Hancock warns end of restrictions ‘long way off’
A representative of the UK’s vaccine advisory committee has defended its decision to delay giving people a second dose, saying it will “save many lives”, as the health secretary, Matt Hancock, warned lifting restrictions was “a long, long way off”.
Prof Anthony Harnden, of the Joint Committee on Vaccination and Immunisation (JCVI), said the evidence was still in favour of delaying the dose, after a small Israeli study on people over the age of 60 suggested a first dose gave just 33% protection from coronavirus.
Continue reading...Exactly a year after his first story about coronavirus, our science editor received the Pfizer injection last week. Here he reflects on a remarkable scientific achievement
I marked a grim anniversary in an unexpected manner last week. On 18 January last year, I wrote my first story about a mysterious disease that had struck Wuhan, in China, and which was now spreading around the world. More than two million individuals have since died of Covid-19, almost 100,000 of them in the UK.
Remarkably, 12 months to the day that the Observer published my story, I was given my first dose of Covid-19 vaccine, allowing me to follow nearly six million other newly immunised UK residents who are set to gain protection against a disease that has brought the planet to a standstill. It was a rare, comforting experience after a year of unremitting sadness and gloom.
Continue reading...British Medical Association warns current 12-week wait could reduce effectiveness of the jab
The gap between the first and second dose of the Pfizer/BioNTech coronavirus vaccine must be reduced to ensure the vaccine is effective, senior doctors have warned.
Currently patients wait about three months to get their second dose. Prof Chris Whitty, the chief medical officer for England, said this was a “public health decision” to get the first jab to more people across the country.
Continue reading...Some survey results show that the overall picture might not be as rosy as implied by others
A quick glance at the government’s coronavirus dashboard might be fuel for optimism. But new data suggests the picture may not be so rosy.
According to the dashboard, the number of people testing positive for Covid is falling: 37,892 positive tests were reported on Thursday, compared with 62,322 on 6 January. Cases by specimen date show similar trends.
Continue reading...Nations outbidding each other creates an ‘immoral race towards the abyss’
Pharmaceutical companies should do more to transfer vaccine technology to prevent the poorest countries falling behind in the distribution of Covid-19 vaccines, according to an expert.
The warning came from Dag-Inge Ulstein, the co-chair of the global council trying to speed up access to Covid vaccines for the world’s poor, known as the Act (Access to Covid-19 Tools) Accelerator. Ulstein, Norway’s international development minister, oversees the drive to ensure vaccines reach the poor – the Covax programme.
Continue reading...My turn for an AstraZeneca dose has come up, so I need to decide whether to drop out of Novavax tests
I had two excellent pieces of news this week. They left me feeling utterly wretched.
First, my turn came up for the AstraZeneca vaccine against Covid. I was told I could have my first jab on Thursday.
Continue reading...